Eugenia Litz
Vice President of Investor Relations
Replay available
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q2 2026 Earnings Call
Recordati Industria Chimica e Farmaceutica S.p.A. (OTC: RCDTF) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Scott Pescatore
Executive Vice President, Rare Diseases
Mike McClellan
Chief Financial Officer (CFO)
Alberto Martinez
Executive Vice President, Specialty and Primary Care
Rob Kormans
Chief Executive Officer (CEO)
Charles Whitwick
Analyst, Barclays
Kirsty Ross-Stewart
Analyst, BNP Paribas
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Recordati S.p.a..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.692 Good afternoon. This is the Corus Call Conference Operator. 00:00:03.692 -- 00:00:09.734 Welcome and thank you for joining the Recordati First Half 2026 Results Conference Call. 00:00:09.734 -- 00:00:13.595 As a reminder, all participants are in listen-only mode. 00:00:13.595 -- 00:00:17.956 After the presentation, there will be an opportunity to ask questions. 00:00:17.956 -- 00:00:22.618 Should anyone need assistance during the conference call, they may signal an operator 00:00:22.618 -- 00:00:26.159 by pressing star and zero on their telephone. 00:00:26.159 -- 00:00:31.252 At this time, I would like to turn the conference over to Miss Eugenia Litz Vice President 00:00:31.252 -- 00:00:35.654 of Investor Relations of Recordati. Please go ahead, madam. 00:00:35.654 -- 00:00:40.577 Thank you, and good afternoon, everyone. I'm pleased to be here today with Rob Kormans, 00:00:40.577 -- 00:00:45.960 our CEO, and Mike McClellan, our CFO, who will present results for the first half 00:00:45.960 -- 00:00:47.741 of 2026. 00:00:47.741 -- 00:00:52.864 Also joining for the Q&A session will be Scott Pescatore, Executive Vice President 00:00:52.864 -- 00:00:58.300 of Rare Diseases, Alberto Martinez, Executive Vice President of Specialty and Primary 00:00:58.300 -- 00:01:03.202 Care, and Milan Draskovic, Executive Vice President of R&D. 00:01:03.202 -- 00:01:08.264 As always, the presentation is available in the investor section of our website. 00:01:08.264 -- 00:01:10.945 It is now my pleasure to pass the call over to Rob. 00:01:10.945 -- 00:01:12.525 Please go ahead. 00:01:12.525 -- 00:01:15.066 Thank you, Eugenia, and good afternoon, everyone. 00:01:15.066 -- 00:01:17.507 Thank you for joining us today. 00:01:17.507 -- 00:01:21.169 We are ver...